ACTN4 and lung carcinoma: Interestingly, a recent study presented a similar regulatory mechanism in lung cancer, where plant homologous structural domain finger protein 23 (PHF23) enhanced the stability of alpha-actinin-4 (ACTN4) by inhibiting its interaction with E3 ligase [41].